Vincenza Nigro
Corporate Officer/Principal at HANSA BIOPHARMA AB
Vincenza Nigro active positions
| Companies | Position | Start | End |
|---|---|---|---|
| HANSA BIOPHARMA AB | Corporate Officer/Principal | 2018-09-16 | - |
| Chief Tech/Sci/R&D Officer | 2018-09-16 | - |
Career history of Vincenza Nigro
Former positions of Vincenza Nigro
| Companies | Position | Start | End |
|---|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Chief Tech/Sci/R&D Officer | - | - |
Training of Vincenza Nigro
| Fairleigh Dickinson University | Undergraduate Degree |
| Massachusetts Institute of Technology | Masters Business Admin |
Statistics
International
| United States | 3 |
| Denmark | 2 |
| Sweden | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| HANSA BIOPHARMA AB | Health Technology |
| Private companies | 1 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Stock Market
- Insiders
- Vincenza Nigro
- Experience
